[ Glooko raises $35M in Series C ]

Glooko has raised $35 million in Series C funding.

Founded in 2010, Glooko offers a cloud based diabetes management system that import blood glucose readings from a range of glucose meters to remotely monitor patients.

Glooko will use the funds to accelerate growth by expanding its sales, marketing and development teams. The company will also increase commercialization efforts in France, Germany, the U.K., Asia and the Middle East, and further development efforts in data analytics and artificial intelligence to provide personalized insights that drive meaningful behavior change.

Funding  Series C
Founded  2010
Country  USA
City  Palo Alto, CA
Founder / CEO  Rick Altinger
Deal Size  $35M
Investors  Georgian Partners
 Samsung NEXT
 Canaan Partners
 Social Capital
 Medtronic
 Insulet
 Mayo Clinic
Previous Investors  Samsung Ventures
 Canaan Partners
 Yogen Dalal
 Social Capital
 Medtronic
 Sundeep Madra
 Vint Cerf
 Xtreme Labs
 Lifeforce Ventures
 Anand Agarawala
 Bill Campbell
 Andy Hertzfeld
 Judy Estrin
 Anand Rajaraman
 Russell Hirsch
 Venky Harinarayan